Genox Research Inc.
Department of Microbiology, Matsumoto Dental University.
Biol Pharm Bull. 2024;47(3):580-590. doi: 10.1248/bpb.b23-00600.
There are 48 nuclear receptors in the human genome, and many members of this superfamily have been implicated in human diseases. The NR4A nuclear receptor family consisting of three members, NR4A1, NR4A2, and NR4A3 (formerly annotated as Nur77, Nurr1, and NOR1, respectively), are still orphan receptors but exert pathological effects on immune-related and neurological diseases. We previously reported that prostaglandin A (PGA) and prostaglandin A (PGA) are potent activators of NR4A3, which bind directly to the ligand-binding domain (LBD) of the receptor. Recently, the co-crystallographic structures of NR4A2-LBD bound to PGA and PGA were reported, followed by reports of the neuroprotective effects of these possible endogenous ligands in mouse models of Parkinson's disease. Based on these structures, we modeled the binding structures of the other two members (NR4A1 and NR4A3) with these potential endogenous ligands using a template-based modeling method, and reviewed the similarity and diversity of ligand-binding mechanisms in the nuclear receptor family.
人类基因组中有 48 个核受体,这个超级家族的许多成员都与人类疾病有关。NR4A 核受体家族由三个成员组成,NR4A1、NR4A2 和 NR4A3(以前分别注释为 Nur77、Nurr1 和 NOR1),仍然是孤儿受体,但对免疫相关和神经退行性疾病有病理影响。我们之前报道过前列腺素 A (PGA) 和前列腺素 A (PGA) 是 NR4A3 的有效激活剂,它们直接与受体的配体结合域 (LBD) 结合。最近,报道了 NR4A2-LBD 与 PGA 和 PGA 结合的共结晶结构,随后报道了这些可能的内源性配体在帕金森病小鼠模型中的神经保护作用。基于这些结构,我们使用基于模板的建模方法对另外两个成员(NR4A1 和 NR4A3)与这些潜在内源性配体的结合结构进行建模,并综述了核受体家族中配体结合机制的相似性和多样性。